Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | Omipalisib | 0.01 | uM | 4 | 312.50 | 180.13 | 171.00 | 257.25 | 0.6647 | -0.0962 |
| SK-BR-3 | 0 | uM | 4 | 312.50 | 180.13 | 273.00 | 257.25 | 1.0612 | 1.2450 | |
| SK-BR-3 | Omipalisib | 0.0033113 | uM | 4 | 312.50 | 180.13 | 214.00 | 257.25 | 0.8319 | 0.3982 |
| SK-BR-3 | Taxol | 0.1 | uM | 4 | 312.50 | 180.13 | 180.00 | 257.25 | 0.6997 | -0.0013 |
| SK-BR-3 | Taxol | 0.001 | uM | 4 | 312.50 | 180.13 | 215.00 | 257.25 | 0.8358 | 0.4109 |
| SK-BR-3 | Palbociclib | 3.1623 | uM | 4 | 312.50 | 180.13 | 195.00 | 257.25 | 0.7580 | 0.1669 |
| SK-BR-3 | Palbociclib | 0.031623 | uM | 4 | 312.50 | 180.13 | 265.00 | 257.25 | 1.0301 | 1.1189 |
| SK-BR-3 | Palbociclib | 19.9526 | uM | 4 | 312.50 | 180.13 | 204.00 | 257.25 | 0.7930 | 0.2739 |
| SK-BR-3 | Omipalisib | 10 | uM | 4 | 312.50 | 180.13 | 121.00 | 257.25 | 0.4704 | -0.5387 |
| SK-BR-3 | 0 | uM | 4 | 312.50 | 180.13 | 313.00 | 257.25 | 1.2167 | 1.9289 | |
| SK-BR-3 | 0 | uM | 4 | 312.50 | 180.13 | 219.00 | 257.25 | 0.8513 | 0.4624 | |
| SK-BR-3 | 0 | uM | 4 | 625.00 | 368.38 | 590.00 | 648.00 | 0.9105 | 0.7826 | |
| SK-BR-3 | 0 | uM | 4 | 625.00 | 368.38 | 737.00 | 648.00 | 1.1373 | 1.3422 | |
| SK-BR-3 | Methotrexate | 0.0016596 | uM | 4 | 625.00 | 368.38 | 593.00 | 648.00 | 0.9151 | 0.7937 |
| SK-BR-3 | Methotrexate | 0.0033113 | uM | 4 | 625.00 | 368.38 | 606.00 | 648.00 | 0.9352 | 0.8421 |
| SK-BR-3 | Methotrexate | 3.1623 | uM | 4 | 625.00 | 368.38 | 494.00 | 648.00 | 0.7624 | 0.4335 |
| SK-BR-3 | Omipalisib | 0.031623 | uM | 4 | 625.00 | 368.38 | 440.00 | 648.00 | 0.6790 | 0.2437 |
| SK-BR-3 | Palbociclib | 0.0033113 | uM | 4 | 625.00 | 368.38 | 608.00 | 648.00 | 0.9383 | 0.8496 |
| SK-BR-3 | 0 | uM | 4 | 625.00 | 368.38 | 630.00 | 648.00 | 0.9722 | 0.9320 | |
| SK-BR-3 | Palbociclib | 0.01 | uM | 4 | 625.00 | 368.38 | 653.00 | 648.00 | 1.0077 | 1.0190 |
| SK-BR-3 | Taxol | 0.00016596 | uM | 4 | 625.00 | 368.38 | 755.00 | 648.00 | 1.1651 | 1.4126 |
| SK-BR-3 | Taxol | 0.031623 | uM | 4 | 625.00 | 368.38 | 323.00 | 648.00 | 0.4985 | -0.1490 |
| SK-BR-3 | Methotrexate | 0.031623 | uM | 4 | 625.00 | 368.38 | 814.00 | 648.00 | 1.2562 | 1.6460 |
| SK-BR-3 | Omipalisib | 0.1 | uM | 4 | 625.00 | 368.38 | 285.00 | 648.00 | 0.4398 | -0.2702 |
| SK-BR-3 | Omipalisib | 0.0016596 | uM | 4 | 625.00 | 368.38 | 596.00 | 648.00 | 0.9198 | 0.8049 |